Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 9
2003 5
2004 12
2005 6
2006 10
2007 6
2008 14
2009 19
2010 24
2011 29
2012 38
2013 25
2014 25
2015 34
2016 32
2017 57
2018 68
2019 74
2020 88
2021 103
2022 92
2023 83
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

751 results

Results by year

Filters applied: . Clear all
Page 1
Edoxaban, Rivaroxaban or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.
Sueta D, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takeda T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Shioyama W, Dohke T, Nishikawa R, Kimura T, Tsujita K. Sueta D, et al. Among authors: morimoto t. Thromb Haemost. 2024 Apr 29. doi: 10.1055/a-2316-5269. Online ahead of print. Thromb Haemost. 2024. PMID: 38684190 Clinical Trial.
Direct oral anticoagulant-associated bleeding complications in patients with gastrointestinal cancer and venous thromboembolism.
Nishimoto Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Sato Y, Watanabe T, Yamada T, Fukunami M, Kimura T; COMMAND VTE Registry-2 Investigators. Nishimoto Y, et al. Among authors: morimoto t. Eur J Intern Med. 2024 Apr 24:S0953-6205(24)00171-7. doi: 10.1016/j.ejim.2024.04.012. Online ahead of print. Eur J Intern Med. 2024. PMID: 38664165
Risk stratification and prognosis prediction using cardiac biomarkers in COVID-19: a single-centre retrospective cohort study.
Sano M, Toyota T, Morimoto T, Noguchi Y, Shigeno R, Murai R, Okada T, Sasaki Y, Taniguchi T, Kim K, Kobori A, Ehara N, Kinoshita M, Doi A, Tomii K, Kihara Y, Furukawa Y. Sano M, et al. Among authors: morimoto t. BMJ Open. 2024 Apr 23;14(4):e082220. doi: 10.1136/bmjopen-2023-082220. BMJ Open. 2024. PMID: 38658000 Free PMC article.
Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis.
Ikeda S, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ono K, Kimura T. Ikeda S, et al. Among authors: morimoto t. Thromb Res. 2024 Apr 19;238:27-36. doi: 10.1016/j.thromres.2024.04.017. Online ahead of print. Thromb Res. 2024. PMID: 38653180
Edoxaban for 12 Versus 3 Months in Cancer-associated Isolated Distal Deep Vein Thrombosis According to Different Doses: Insights from the ONCO DVT study.
Chatani R, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mushiake K, Kadota K, Ono K, Kimura T. Chatani R, et al. Among authors: morimoto t. Eur Heart J Cardiovasc Pharmacother. 2024 Apr 22:pvae028. doi: 10.1093/ehjcvp/pvae028. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38650055
Rationale and protocol for a prospective cohort study of respiratory viral infections in patients admitted from emergency departments of community hospitals: Effect of respiratory Virus infection on EmeRgencY admission (EVERY) study.
Morimoto T, Morikawa T, Imura H, Nezu M, Hamazaki K, Sakuma M, Chaumont A, Moitinho de Almeida M, Moreno VP, Ho Y, Harrington L, Matsuki T, Nakamura T. Morimoto T, et al. BMJ Open. 2024 Apr 15;14(4):e081037. doi: 10.1136/bmjopen-2023-081037. BMJ Open. 2024. PMID: 38626982 Free PMC article.
One-year morbidity and mortality in patients treated with standard-dose and low-dose apixaban after acute large vessel occlusion stroke.
Murakami Y, Todo K, Uchida K, Yamagami H, Sakai N, Gon Y, Okazaki S, Sasaki T, Yoshimura S, Morimoto T, Mochizuki H. Murakami Y, et al. Among authors: morimoto t. J Thromb Thrombolysis. 2024 Apr;57(4):622-629. doi: 10.1007/s11239-024-02954-7. Epub 2024 Mar 31. J Thromb Thrombolysis. 2024. PMID: 38556577 Free PMC article.
751 results